Engineered oncolytic adenovirus (VIDEO)

Emory Health Sciences

Caption

Engineered adenovirus Ad5-3M with highlighted in red mutations that were introduced to target virus to tumor cells, reduce inflammation, and avoid interactions with blood factors and immune cells after systemic administration

Credit

Phoebe Stewart

Usage Restrictions

In connection with Science Translational Medicine paper.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.